Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

NCT00003335 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Graft Versus Host Disease
Leukemia
Lymphoma
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases

Interventions

BIOLOGICAL: anti-thymocyte globulin
DRUG: busulfan
DRUG: cyclosporine
DRUG: melphalan
DRUG: methylprednisolone
PROCEDURE: umbilical cord blood transplantation
RADIATION: radiation therapy

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]